WEScover: selection between clinical whole exome sequencing and gene panel testing
Background: Whole exome sequencing (WES) is widely adopted in clinical and research settings; however, one of the practical concerns is the potential false negatives due to incomplete breadth and depth of coverage for several exons in clinically implicated genes. In some cases, a targeted gene panel...
Main Authors: | Alvarez, W.J (Author), Hernandez-Ferrer, C. (Author), Kong, S.W (Author), Lee, I.-H (Author), Lin, Y. (Author), Mandl, K.D (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
BioMed Central Ltd
2021
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
WEScover: selection between clinical whole exome sequencing and gene panel testing
by: In-Hee Lee, et al.
Published: (2021-05-01) -
From Genomes to GENE-omes: Exome Sequencing Concept and Applications in Crop Improvement
by: Parampreet Kaur, et al.
Published: (2017-12-01) -
Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes
by: Paul Dunn, et al.
Published: (2018-02-01) -
Patterns of Whole Exome Sequencing in Resected Cholangiocarcinoma
by: Lucas W. Thornblade, et al.
Published: (2021-08-01) -
The Role and Challenges of Exome Sequencing in Studies of Human Diseases
by: Zuoheng eWang, et al.
Published: (2013-08-01)